Given the observation that soluble p-tau increases early in AD and prior to the formation of neocortical insoluble tau aggregates, we then tested whether measures related to the accumulation rate of insoluble tau aggregates mediated the association between soluble p-tau concentrations and subsequent cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.